Conversations
Five labs replicate psilocybin mouse experiment in parallel; most lasting behavioral effects fail to reproduce
Five laboratories at UC Berkeley, UC San Francisco, and Stanford tested psilocybin’s effects in mice using the same protocol. Pooled results showed no reproducible lasting behavioral changes 24 hours after a single dose, but increased anxiety and avoidance and reduced fear expression 10 minutes after injection were reproducible.
This multilaboratory study aimed to clarify conflicting findings from previous animal and human trials and establish a more reliable baseline for the behavioral effects of psilocybin research. The five labs used the same parallel experimental protocol and observed indicators such as anxiety, depression-like behavior, fear responses, and social interaction after administration.
Pooled data showed that 24 hours after mice received a single dose of psilocybin, the research team found no lasting behavioral changes and did not reproduce previously reported reductions in anxiety or depression-like behavior, changes in fear responses, or improvements in social interaction. The team also tested whether the drug could reopen a critical period for social-reward learning in adult mice and found no supporting evidence.
Acute effects were more stable. All five labs reported that mice showed increased anxiety and avoidance behavior 10 minutes after injection, along with decreased fear expression. The researchers believe these reproducible acute responses can serve as an entry point for subsequent studies of neural-circuit mechanisms.
The paper was published in Nature Neuroscience on November 2, 2026. Participants said multilaboratory collaboration helps estimate true effect sizes more accurately and reduces the risk of publication bias caused by positive results from small samples and single experiments.